News
Prostate Cancer Trial Will Use 3D Signatures Genome Biomarker Tests Oct 19, 2016 a GenomeWeb staff reporter This article...
Canadian patients will be enrolled in clinical trials led by McGill and funded by the Weston Brain Institute October 3, 2016 – Montreal, QC...
There’s a tremendous amount of precision required from pathologists when they make cancer diagnoses, and the results of their work are...
CIMTEC spin-off company, Focal Healthcare, announced on January 29, 2016 that it has received 510(k) clearance from the U.S. Food and Drug...
Are you a Canadian Life Sciences Entrepreneur looking for capital to grow your business? The Consulate General of Canada in New York and...
Feature article in Biotechnology Focus by Darlene Pratt, CIMTEC's Director of Marketing Communications Arguably, the most formidable...
Former CIMTEC customer, Densitas Inc., received regulatory approval for its first commerical software technology. DM-Density provides...
CIMTEC is pleased to announce its collaboration with Proteocyte Diagnostics Inc., which has developed a novel diagnostic technology, called...
Tickets now available for gala to support Alzheimer Society of Toronto: Hosted by broadcaster and author, Jay Ingram September 29, 2015 –...
Developing proprietary analytical tools to conduct three-dimensional genomic analyses September 10, 2015 – Winnipeg, MB ─ 3D Signatures Inc...
